Table 3.
Procedural and clinical outcomes.
| Outcomes, N (%) |
All (N = 181) |
TAVI (N = 132) |
SAVR (N = 18) |
OMT (N = 31) |
|---|---|---|---|---|
| Procedural mortality (N = 150) | 2 (1.3) | 1 (0.8) | 1 (5.6) | N/A |
| 30-day mortality | 6 (3.3) | 3 (2.3) | 2 (11.1) | 1 (3.2) |
| 6 month all-cause morality | 21 (11.8) | 12 (9.3) | 3 (16.7) | 6 (19.4) |
| Stroke/TIA | 6 (3.6) | 3 (2.5) | 1 (5.6) | 2 (7.1) |
| Procedural complications | ||||
| Myocardial Infarction | 1 (0.7) | 0 (0) | 1 (5.6) | N/A |
| Any bleeding | 19 (12.7) | 14 (10.6) | 5 (27.8) | N/A |
| Life-threatening bleeding | 8 (5.3) | 5 (3.8) | 3 (16.7) | N/A |
| Acute kidney injury | 12 (8) | 6 (4.5) | 6 (33.3) | N/A |
| Any vascular complication | 12 (8) | 12 (9.1) | 0 (0) | N/A |
| Major vascular complication | 6 (4) | 6 (4.5) | 0 (0) | N/A |
| New permanent pacemaker | 27 (18) | 25 (18.9) | 2 (11.1) | N/A |
Values are number (%). TAVI, transcatheter aortic valve implantation; SAVR, surgical aortic valve replacement; OMT, optimal medical therapy; TIA, transient ischaemic attack.